Abstract
Vitamin D has been used in the context of secondary hyperparathyroidism in patients with end-stage renal disease. A wave of recent studies suggests that vitamin D treatment may be associated with decreased mortality risk in these patients. The article by Wolf et al. further supports these studies by identifying vitamin D deficiency as a risk factor for early mortality in incident hemodialysis patients.
MeSH terms
-
Humans
-
Hyperparathyroidism / drug therapy
-
Hyperparathyroidism / etiology
-
Hyperparathyroidism / metabolism
-
Kidney Failure, Chronic / complications*
-
Kidney Failure, Chronic / metabolism*
-
Kidney Failure, Chronic / therapy
-
Randomized Controlled Trials as Topic
-
Renal Dialysis / adverse effects*
-
Risk Factors
-
Survival Analysis
-
Vitamin D / metabolism*
-
Vitamin D / therapeutic use
-
Vitamin D Deficiency / complications*
-
Vitamin D Deficiency / drug therapy
-
Vitamin D Deficiency / metabolism